Literature DB >> 10333489

Relationship between cytochrome P450 catalytic cycling and stability: fast degradation of ethanol-inducible cytochrome P450 2E1 (CYP2E1) in hepatoma cells is abolished by inactivation of its electron donor NADPH-cytochrome P450 reductase.

A Zhukov1, M Ingelman-Sundberg.   

Abstract

Ethanol-inducible cytochrome P450 2E1 (CYP2E1) involved in the metabolism of gluconeogenetic precursors and some cytotoxins is distinguished from other cytochrome P450 enzymes by its rapid turnover (in vivo half-life of 4-7 h), with ligands to the haem iron, both substrates and inhibitors, stabilizing the protein. CYP2E1 is also known to have a high oxidase activity in the absence of substrate, resulting in the production of reactive oxygen radicals. We suggested that the rapid intracellular turnover of the enzyme may be partly due to covalent modifications by such radicals or to other changes during catalytic cycling, in which case the inhibition of electron supply from NADPH-cytochrome P450 reductase would be expected to stabilize the protein. Fao hepatoma cells, where CYP2E1 showed a half-life of 4 h upon serum withdrawal, were treated for 1 h with 0.3 microM diphenylene iodonium (DPI), a suicide inhibitor of flavoenzymes, which resulted in approximately 90% inhibition of the microsomal NADPH-cytochrome P450 reductase and CYP2E1-dependent chlorzoxazone hydroxylase activities. Subsequent cycloheximide chase revealed that the CYP2E1 half-life increased to 26 h. Neither the degradation rates of total protein, CYP2B1 and NADPH-cytochrome P450 reductase nor the cellular ATP level were affected by DPI under the conditions employed. These results demonstrate for the first time that the short half-life of CYP2E1 in vivo may be largely due to the rapid destabilization of the enzyme during catalytic cycling rather than to the intrinsic instability of the protein molecule.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10333489      PMCID: PMC1220271     

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  48 in total

1.  Spin state control of the hepatic cytochrome P450 redox potential.

Authors:  S G Sligar; D L Cinti; G G Gibson; J B Schenkman
Journal:  Biochem Biophys Res Commun       Date:  1979-10-12       Impact factor: 3.575

2.  Coupling of spin, substrate, and redox equilibria in cytochrome P450.

Authors:  S G Sligar
Journal:  Biochemistry       Date:  1976-11-30       Impact factor: 3.162

3.  Hepatic microsomal ethanol oxidation. Hydrogen peroxide formation and the role of catalase.

Authors:  R G Thurman; H G Ley; R Scholz
Journal:  Eur J Biochem       Date:  1972-02

4.  Induction of CYP2E1 in liver, kidney, brain and intestine during chronic ethanol administration and withdrawal: evidence that CYP2E1 possesses a rapid phase half-life of 6 hours or less.

Authors:  B J Roberts; S E Shoaf; K S Jeong; B J Song
Journal:  Biochem Biophys Res Commun       Date:  1994-12-15       Impact factor: 3.575

5.  Turnover of two drug-inducible forms of microsomal cytochrome P-450 in rat liver.

Authors:  H Sadano; T Omura
Journal:  J Biochem       Date:  1983-05       Impact factor: 3.387

6.  Hepatic microsomal cytochrome P-450 from rats treated with isosafrole. Purification and characterization of four enzymic forms.

Authors:  D E Ryan; P E Thomas; W Levin
Journal:  J Biol Chem       Date:  1980-08-25       Impact factor: 5.157

7.  Purification and characterization of a unique isozyme of cytochrome P-450 from liver microsomes of ethanol-treated rabbits.

Authors:  D R Koop; E T Morgan; G E Tarr; M J Coon
Journal:  J Biol Chem       Date:  1982-07-25       Impact factor: 5.157

8.  The effects of diphenyleneiodonium on mitochondrial reactions. Relation of binding of diphenylene[125I]iodonium to mitochondria to the extent of inhibition of oxygen uptake.

Authors:  S J Gatley; S A Sherratt
Journal:  Biochem J       Date:  1976-08-15       Impact factor: 3.857

9.  Catalytic activity of cytochrome P-450 isozyme 3a isolated from liver microsomes of ethanol-treated rabbits. Oxidation of alcohols.

Authors:  E T Morgan; D R Koop; M J Coon
Journal:  J Biol Chem       Date:  1982-12-10       Impact factor: 5.157

10.  Oxidation-reduction properties of rat liver cytochromes P-450 and NADPH-cytochrome p-450 reductase related to catalysis in reconstituted systems.

Authors:  F P Guengerich
Journal:  Biochemistry       Date:  1983-06-07       Impact factor: 3.162

View more
  19 in total

1.  Ubiquitin-dependent proteasomal degradation of human liver cytochrome P450 2E1: identification of sites targeted for phosphorylation and ubiquitination.

Authors:  YongQiang Wang; Shenheng Guan; Poulomi Acharya; Dennis R Koop; Yi Liu; Mingxiang Liao; Alma L Burlingame; Maria Almira Correia
Journal:  J Biol Chem       Date:  2011-01-05       Impact factor: 5.157

Review 2.  Hepatic cytochromes P450: structural degrons and barcodes, posttranslational modifications and cellular adapters in the ERAD-endgame.

Authors:  Sung-Mi Kim; YongQiang Wang; Noushin Nabavi; Yi Liu; Maria Almira Correia
Journal:  Drug Metab Rev       Date:  2016-06-20       Impact factor: 4.518

3.  Post-transcriptional Regulation of UGT2B10 Hepatic Expression and Activity by Alternative Splicing.

Authors:  Adrien Labriet; Eric P Allain; Michèle Rouleau; Yannick Audet-Delage; Lyne Villeneuve; Chantal Guillemette
Journal:  Drug Metab Dispos       Date:  2018-02-09       Impact factor: 3.922

4.  Liver cytochrome P450 3A ubiquitination in vivo by gp78/autocrine motility factor receptor and C terminus of Hsp70-interacting protein (CHIP) E3 ubiquitin ligases: physiological and pharmacological relevance.

Authors:  Sung-Mi Kim; Poulomi Acharya; Juan C Engel; Maria Almira Correia
Journal:  J Biol Chem       Date:  2010-09-06       Impact factor: 5.157

Review 5.  Cytochrome P450 regulation: the interplay between its heme and apoprotein moieties in synthesis, assembly, repair, and disposal.

Authors:  Maria Almira Correia; Peter R Sinclair; Francesco De Matteis
Journal:  Drug Metab Rev       Date:  2010-09-23       Impact factor: 4.518

Review 6.  Hepatic cytochrome P450 ubiquitination: conformational phosphodegrons for E2/E3 recognition?

Authors:  Maria Almira Correia; YongQiang Wang; Sung-Mi Kim; Shenheng Guan
Journal:  IUBMB Life       Date:  2014-02-03       Impact factor: 3.885

7.  Differential induction of ethanol-metabolizing CYP2E1 and nicotine-metabolizing CYP2B1/2 in rat liver by chronic nicotine treatment and voluntary ethanol intake.

Authors:  Jiang Yue; Jibran Khokhar; Sharon Miksys; Rachel F Tyndale
Journal:  Eur J Pharmacol       Date:  2009-03-13       Impact factor: 4.432

8.  A role for protein phosphorylation in cytochrome P450 3A4 ubiquitin-dependent proteasomal degradation.

Authors:  Yongqiang Wang; Mingxiang Liao; Nicholas Hoe; Poulomi Acharya; Changhui Deng; Andrew N Krutchinsky; Maria Almira Correia
Journal:  J Biol Chem       Date:  2008-12-18       Impact factor: 5.157

9.  Protective effects of diallyl sulfide, a garlic constituent, on the warm hepatic ischemia-reperfusion injury in a rat model.

Authors:  Imam H Shaik; Jancy M George; Thomas J Thekkumkara; Reza Mehvar
Journal:  Pharm Res       Date:  2008-07-15       Impact factor: 4.200

Review 10.  Human drug metabolising cytochrome P450 enzymes: properties and polymorphisms.

Authors:  Magnus Ingelman-Sundberg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-10-22       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.